Biodyne Statistics

Total Valuation

Biodyne has a market cap or net worth of KRW 496.47 billion. The enterprise value is 476.13 billion.

Market Cap	496.47B
Enterprise Value	476.13B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Biodyne has 29.76 million shares outstanding. The number of shares has decreased by -17.22% in one year.

Current Share Class	29.76M
Shares Outstanding	29.76M
Shares Change (YoY)	-17.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	46.19%
Owned by Institutions (%)	1.09%
Float	16.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	97.69
PB Ratio	11.61
P/TBV Ratio	12.53
P/FCF Ratio	n/a
P/OCF Ratio	888.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2,151.83
EV / Sales	93.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7,386.92

Financial Position

The company has a current ratio of 20.89, with a Debt / Equity ratio of 0.00.

Current Ratio	20.89
Quick Ratio	20.26
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-12,324.78

Financial Efficiency

Return on equity (ROE) is -0.52% and return on invested capital (ROIC) is -3.04%.

Return on Equity (ROE)	-0.52%
Return on Assets (ROA)	-2.97%
Return on Invested Capital (ROIC)	-3.04%
Return on Capital Employed (ROCE)	-4.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	5.24

Taxes

Income Tax	-340.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.63% in the last 52 weeks. The beta is 1.83, so Biodyne's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	+9.63%
50-Day Moving Average	15,443.20
200-Day Moving Average	15,959.10
Relative Strength Index (RSI)	43.09
Average Volume (20 Days)	137,609

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biodyne had revenue of KRW 5.08 billion and -221.27 million in losses. Loss per share was -7.48.

Revenue	5.08B
Gross Profit	2.66B
Operating Income	-2.08B
Pretax Income	-561.56M
Net Income	-221.27M
EBITDA	-481.78M
EBIT	-2.08B
Loss Per Share	-7.48

Full Income Statement

Balance Sheet

The company has 20.34 billion in cash and 8.67 million in debt, giving a net cash position of 20.34 billion or 683.23 per share.

Cash & Cash Equivalents	20.34B
Total Debt	8.67M
Net Cash	20.34B
Net Cash Per Share	683.23
Equity (Book Value)	42.76B
Book Value Per Share	1,450.79
Working Capital	20.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 558.87 million and capital expenditures -623.33 million, giving a free cash flow of -64.46 million.

Operating Cash Flow	558.87M
Capital Expenditures	-623.33M
Free Cash Flow	-64.46M
FCF Per Share	-2.17

Full Cash Flow Statement

Margins

Gross margin is 52.42%, with operating and profit margins of -40.99% and -4.35%.

Gross Margin	52.42%
Operating Margin	-40.99%
Pretax Margin	-11.05%
Profit Margin	-4.35%
EBITDA Margin	-9.48%
EBIT Margin	-40.99%
FCF Margin	n/a

Dividends & Yields

Biodyne does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	17.22%
Shareholder Yield	n/a
Earnings Yield	-0.04%
FCF Yield	-0.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Feb 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Biodyne has an Altman Z-Score of 251.9 and a Piotroski F-Score of 4.

Altman Z-Score	251.9
Piotroski F-Score	4